Healthcare -
Biotechnology - NASDAQ - US
$ 6.385
3.15 %
$ 286 M
Market Cap
-11.82
P/E
YMAB - STOCK-BASED COMPENSATION
Stock-based Compensation YMAB - Y-mAbs Therapeutics, Inc.
14.5 M
LAST VALUE
-13.54%
2 YEAR CAGR
49.03%
5 YEAR CAGR
0.00%
10 YEAR CAGR